The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2024

Filed:

Jun. 04, 2020
Applicant:

Spiritus Therapeutics, Inc., New York, NY (US);

Inventors:

Jodi Gurney, New York, NY (US);

Robin Smith, New York, NY (US);

Assignee:

Spiritus Therapeutics, Inc., New York, NY (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/28 (2015.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 35/17 (2015.01); A61K 45/06 (2006.01); A61P 11/00 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 9/0073 (2013.01); A61K 9/127 (2013.01); A61K 35/17 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2018.01); C12N 15/113 (2013.01);
Abstract

The described invention provides compositions and methods for treating a susceptible subject at risk of pulmonary complications of an acute lung injury caused by a severe infection with a respiratory virus and for restoring lung function to donor lungs. The methods include administering a therapeutic amount of a pharmaceutical composition comprising extracellular vesicles (EVs) comprising one or more miRNAs and a pharmaceutically acceptable carrier. The population of EVs can be derived from a patient who has recovered from an infection with the respiratory virus or has been exposed to anti-viral antibodies through treatment, can be derived from MSCs of a normal healthy individual, can be modified by a viral vector, or can be synthetic.


Find Patent Forward Citations

Loading…